Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack

BACKGROUND AND PURPOSE: In patients with acute mild-moderate ischemic stroke or high-risk transient ischemic attack, the THALES trial (Acute Stroke or Transient Ischemic Attack Treated With Ticagrelor and Aspirin for Prevention of Stroke and Death) demonstrated that when added to aspirin, ticagrelor...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnston, S. Claiborne, Amarenco, Pierre, Aunes, Maria, Denison, Hans, Evans, Scott R., Himmelmann, Anders, Jahreskog, Marianne, James, Stefan, Knutsson, Mikael, Ladenvall, Per, Molina, Carlos A., Nylander, Sven, Röther, Joachim, Wang, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547576/
https://www.ncbi.nlm.nih.gov/pubmed/34477459
http://dx.doi.org/10.1161/STROKEAHA.121.035555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547576/
https://www.ncbi.nlm.nih.gov/pubmed/34477459
http://dx.doi.org/10.1161/STROKEAHA.121.035555

Ejemplares similares